RNeasy Fibrous Tissue Mini Kit – RNA Extraction

For purification of up to 100 µg total RNA from fiber-rich tissues

S_1274_GEF_RNALT0219

✓ 24/7 automatic processing of online orders

✓ Knowledgeable and professional Product & Technical Support

✓ Fast and reliable (re)-ordering

RNeasy Fibrous Tissue Mini Kit (50)

Cat no. / ID.   74704

50 RNeasy Mini Spin Columns, Collection Tubes (1.5 ml and 2 ml), Proteinase K, RNase-free DNase I, RNase-free Reagents and Buffers
$553.00
Log in To see your account pricing.
The RNeasy Fibrous Tissue Mini Kit is intended for molecular biology applications. This product is not intended for the diagnosis, prevention, or treatment of a disease.

✓ 24/7 automatic processing of online orders

✓ Knowledgeable and professional Product & Technical Support

✓ Fast and reliable (re)-ordering

Features

  • Optimized protocols for fibrous tissues
  • High yields of total RNA
  • High-quality RNA for all downstream applications
  • Removal of genomic DNA using DNase I

Product Details

The RNeasy Fibrous Tissue Mini Kit includes proteinase K for removing abundant protein in fiber-rich tissue samples, and RNeasy spin columns for purifying up to 100 µg of high-quality RNA. The kit can be automated on the QIAcube Connect. Fibrous tissue samples can be conveniently stabilized using RNAprotect Tissue Reagent or Allprotect Tissue Reagent, and efficiently disrupted using a TissueRuptor or TissueLyser system. For larger samples, the RNeasy Fibrous Tissue Midi Kit (spin-column binding capacity of 1 mg RNA) is also available.

Performance

RNeasy Fibrous Tissue Kits are optimized for use with fiber-rich tissues and the RNeasy Fibrous Tissue procedure ensures easy and efficient isolation of high-quality total RNA (see figure " High-quality RNA from fiber-rich tissues") suitable for any downstream application, including array analysis and real-time RT-PCR (see figures " Real-time gene expression analysis in a variety of fibrous tissues" and " LightCycler analysis of high-quality RNA from heart"). The RNeasy Fibrous Tissue Mini Kit ensures higher yields of RNA from fiber-rich tissue compared with other silica-based methods (see table).

 

Highest RNA yields using RNeasy Fibrous Tissue Kits compared with other silica-based methods
Rat tissue
(10 mg)
RNA yield* (µg) with
RNeasy Fibrous
Tissue Mini Kit
RNA yield* (µg) with
silica kit (Supplier AV
RNA yield* (µg) with
silica kit (Supplier R)
RNA yield* (µg) with
silica kit (Supplier S)
Heart 8.2 3.5 <0.5 2.5
Muscle 5.3 0.5 2.0 2.2
Skin 6.0 Not determined Not determined Not determined
Esophagus 13.9 Not determined Not determined Not determined
See figures

Principle

RNeasy technology simplifies total RNA isolation by combining the stringency of guanidine-isothiocyanate lysis with the speed and purity of silica-membrane purification. RNeasy Fibrous Tissue Kits are optimized for use with fiber-rich tissues, such as skeletal muscle, heart, and aorta, tissues difficult to lyse due to the abundance of contractile proteins, connective tissue, and collagen. The RNeasy Fibrous Tissue protocol integrates proteinase K and RNase-free DNase digestion steps during RNA isolation to break down proteins and genomic DNA for higher yields of high-quality total RNA. Since the RNeasy procedures enrich for mRNA and other RNA species >200 nucleotides, the total RNA yield does not include 5S rRNA, tRNA, and other low-molecular-weight RNAs, which make up 15-20% of total cellular RNA.

Procedure

Samples of fibrous tissue from 0.5–30 mg are lysed in a guanidine-isothiocyanate buffer. After dilution of the lysate, the sample is treated with proteinase K. Debris is pelleted by centrifugation. Ethanol is then added to the cleared lysate, and RNA is bound to the RNeasy silica membrane. Traces of DNA that may copurify are removed by a DNase treatment on the RNeasy spin column. DNase and any contaminants are washed away, and up to 100 µg high-quality total RNA is eluted in 30–100 µl RNase-free water (see figure " RNeasy Fibrous Tissue Mini procedure").

See figures

Applications

RNeasy Fibrous Tissue Kits provide high-quality total RNA from fiber-rich samples that is suitable for any downstream application, including array analysis and real-time RT-PCR.

Supporting data and figures

Specifications

FeaturesSpecifications
applicationsPCR, real-time PCR, microarray
elutionvolume30–100 µl
formatSpin column
timeperrunorperprep55 minutes
purificationoftotalrnamirnapolyamrnadnaorproteinRNA
processingManual
sampleamount0.5–30 mg
technologySilica technology
mainsampletypeFibre-rich tissue samples
yield5–12 µg

Resources

Safety Data Sheets (1)
Download Safety Data Sheets for QIAGEN product components.
Kit Handbooks (1)
Quick-Start Protocols (1)
Gene Expression Analysis (1)
Certificates of Analysis (1)

Publications

Myofilament response to Ca2+ and Na+/H+ exchanger activity in sex hormone-related protection of cardiac myocytes from deactivation in hypercapnic acidosis.
Bupha-Intr T; Wattanapermpool J; Peña JR; Wolska BM; Solaro RJ;
Am J Physiol Regul Integr Comp Physiol; 2006; 292 (2):R837-43 2006 Oct 12 PMID:17038443
A study of alternative splicing in the pig.
Nygard AB; Cirera S; Gilchrist MJ; Gorodkin J; Jørgensen CB; Fredholm M;
BMC Res Notes; 2010; 3 :123 2010 May 5 PMID:20444244
Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats.
Aoki T; Kataoka H; Morimoto M; Nozaki K; Hashimoto N;
Stroke; 2006; 38 (1):162-9 2006 Nov 22 PMID:17122420
Matrix metalloproteinase and tissue inhibitor expression in atherosclerotic and nonatherosclerotic thoracic aortic aneurysms.
Schmoker JD; McPartland KJ; Fellinger EK; Boyum J; Trombley L; Ittleman FP; Terrien C 3rd; Stanley A; Howard A;
J Thorac Cardiovasc Surg; 2007; 133 (1):155-61 2007 Jan PMID:17198804
Use of an aggressive MCF-7 cell line variant, TMX2-28, to study cell invasion in breast cancer.
Gozgit JM; Pentecost BT; Marconi SA; Otis CN; Wu C; Arcaro KF;
Mol Cancer Res; 2006; 4 (12):905-13 2006 Dec PMID:17189381